{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:53:30Z","timestamp":1782140010036,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T00:00:00Z","timestamp":1194307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T00:00:00Z","timestamp":1194307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s00403-007-0813-2","type":"journal-article","created":{"date-parts":[[2007,11,5]],"date-time":"2007-11-05T08:28:15Z","timestamp":1194251295000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of outcome measures for autoimmune dermatoses"],"prefix":"10.1007","volume":"300","author":[{"given":"Elizabeth","family":"Gaines","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,6]]},"reference":[{"key":"813_CR1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","volume":"125","author":"J Albrecht","year":"2005","unstructured":"Albrecht J, Taylor L, Berlin J et al (2005) The CLASI (cutaneous lupus erythematosus disease area severity and index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 125:889\u2013894","journal-title":"J Invest Dermatol"},{"key":"813_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1529-8019.2007.00117.x","volume":"20","author":"J Albrecht","year":"2007","unstructured":"Albrecht J, Werth VP (2007) Development of the CLASI as an outcome instrument in cutaneous lupus erythematosus. Dermatol Ther 20:93\u2013101","journal-title":"Dermatol Ther"},{"issue":"11","key":"813_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","volume":"142","author":"S Beissert","year":"2006","unstructured":"Beissert S, Werfel T, Frieling U, Bohm M, Sticherling M, Stadler R, Zillikens D, Rzany B, Hunzelmann N, Meurer M, Gollnick H, Ruzicka T, Pillekamp H, Junghans V, Luger TA (2006) A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 142(11):1447\u20131454","journal-title":"Arch Dermatol"},{"issue":"6","key":"813_CR4","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombaridier","year":"1992","unstructured":"Bombaridier C, Gladmann DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studied in SLE. Arthritis Rheum 35(6):630\u2013640","journal-title":"Arthritis Rheum"},{"key":"813_CR5","unstructured":"Bonilla-Martinez Z, Albrecht J, Taylor L, Okawa J, Dulay S, Werth V (2007) The CLASI is a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus. Arch Dermatol (in press)"},{"key":"813_CR6","unstructured":"Center for Drug Evaluation and Research (CDER) (2005) Systemic lupus erythematosus\u2014developing drugs for treatment (Guidance for Industry\u2014Draft). http:\/\/www.fda.gov\/CDER\/guidance\/6496dft.htm. Accessed 24 March 2007"},{"key":"813_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archderm.136.6.763","volume":"136","author":"C Charman","year":"2000","unstructured":"Charman C, Williams H (2000) Outcome measures of disease severity in atopic eczema. Arch Dermatol 136:763\u2013769","journal-title":"Arch Dermatol"},{"key":"813_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-2133.1999.02617.x","volume":"140","author":"CR Charman","year":"1999","unstructured":"Charman CR, Venn AJ, Williams HC (1999) Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 140:109\u2013111","journal-title":"Br J Dermatol"},{"key":"813_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archderm.115.5.571","volume":"115","author":"CH Cook","year":"1979","unstructured":"Cook CH, Centner RL, Michaels SE (1979) An acne grading method using photographic standards. Arch Dermatol 115:571\u2013575","journal-title":"Arch Dermatol"},{"key":"813_CR10","unstructured":"Concept paper systematic lupus erythematosus 09\/16\/2003. 1-4-1901 (Pamplet)"},{"issue":"Suppl II","key":"813_CR11","doi-asserted-by":"publisher","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","volume":"64","author":"SR Feldman","year":"2005","unstructured":"Feldman SR, Krueger GG (2005) Psoriasis asseessment tools in clinical trials. Ann Rheum Dis 64 (Suppl II):ii65\u2013ii68","journal-title":"Ann Rheum Dis"},{"key":"813_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2133.1996.tb03822.x","volume":"135","author":"AY Finlay","year":"1996","unstructured":"Finlay AY (1996) Measurement of disease activity and outcome in atopic dermatitis. Br J Dermatol 135:509\u2013515","journal-title":"Br J Dermatol"},{"key":"813_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2230.1987.tb01844.x","volume":"12","author":"AY Finlay","year":"1987","unstructured":"Finlay AY, Kelly SE (1987) Psoriasis\u2014an index of disability. Clin Exp Dermatol 12:8\u201311","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"813_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/096120339600500305","volume":"5","author":"DD Gladman","year":"1996","unstructured":"Gladman DD, Urowitz MB, Ong A et al (1996) A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 5(3):190\u2013195","journal-title":"Lupus"},{"issue":"1","key":"813_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2230.2005.02001.x","volume":"31","author":"B Hahn","year":"2006","unstructured":"Hahn B, Chuang TY (2006) Using the dermatology index of disease severity (DIDS) to assess the responsiveness of dermatitis. Clin Exp Dermatol 31(1):19\u201322","journal-title":"Clin Exp Dermatol"},{"key":"813_CR16","first-page":"359","volume":"127","author":"RQ Klein","year":"2007","unstructured":"Klein RQ, Bangert CC, Costner M et al (2007) Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. J Invest Dermatol 127:359 (Abstract #249)","journal-title":"J Invest Dermatol"},{"key":"813_CR17","first-page":"S8","volume":"127","author":"MS Krathen","year":"2007","unstructured":"Krathen MS et al (2007) The cutaneous lupus erythematosus disease area severity and index (CLASI) reliability and validity assessment: expansion for rheumatology and dermatology and evaluation with spectroscopy. J Invest Dermatol 127:S8 (Abstract #48)","journal-title":"J Invest Dermatol"},{"issue":"1","key":"813_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","volume":"195","author":"B Kunz","year":"1997","unstructured":"Kunz B, Oranje AP, Labr\u00e8ze L, Stalder JF, Ring J, Ta\u00efeb A (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology 195(1):10\u201319","journal-title":"Dermatology"},{"key":"813_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0190-9622(96)90680-5","volume":"35","author":"AW Lucky","year":"1996","unstructured":"Lucky AW, Barber BL, Girman CJ, Williams J, Ratterman J, Waldstreicher J (1996) A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 35:559\u2013565","journal-title":"J Am Acad Dermatol"},{"key":"813_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archderm.142.5.570","volume":"142","author":"LF Mentink","year":"2006","unstructured":"Mentink LF, Mackenzie MW, Gabor G et al (2006) Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris. Arch Dermatol 142:570","journal-title":"Arch Dermatol"},{"key":"813_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archderm.135.4.407","volume":"135","author":"MD Njoo","year":"1999","unstructured":"Njoo MD, Das PK et al (1999) Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135:407\u2013413","journal-title":"Arch Dermatol"},{"issue":"3","key":"813_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2133.2000.03356.x","volume":"142","author":"A Parodi","year":"2000","unstructured":"Parodi A, Massone C, Cacciapuoti M et al (2000) Measuring the activity of disease in patients with cutaneous lupus erythematosus. Br J Dermatol 142(3):457\u2013460","journal-title":"Br J Dermatol"},{"key":"813_CR23","unstructured":"Plewig G, Jansen T (1999) Rosacea, Chap 74, pp 785\u2013794 (Table 74-1, p 786). In: Freedburg IM, Eisen AZ et al (eds) Fitzpatrick\u2019s dermatology in general medicine, 5th edn. McGraw-Hill, New York (1999)"},{"issue":"1","key":"813_CR24","first-page":"4","volume":"17","author":"M Pfutze","year":"2007","unstructured":"Pfutze M, Niedermeier A, Hertl M, Eming R (2007) Introducing a novel autoimmune bullous skin disorder intensity score (ABSIS) in pemphigus. Eur J Dermatol 17(1):4\u201311","journal-title":"Eur J Dermatol"},{"key":"813_CR25","first-page":"S57","volume":"127","author":"RD Quain","year":"2007","unstructured":"Quain RD, Teal V, Taylor L, Werth VP (2007) Number, characteristics, and classification of dermatomyositis patients seen by dermatology and rheumatology at a tertiary medical center. J Invest Dermatol 127:S57 (Abstract #340)","journal-title":"J Invest Dermatol"},{"key":"813_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1365-2133.1991.tb04952.x","volume":"124","author":"B Ramsay","year":"1991","unstructured":"Ramsay B, Lawrence CM (1991) Measurement of involved surface area in patients with psoriasis. Br J Dermatol 124:565\u2013570","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"813_CR27","first-page":"S168","volume":"38","author":"LG Rider","year":"1995","unstructured":"Rider LG, Lachenbruch PA, Rennebohm RM et al (1995) Identifying skin lesions in dermatomyositis (DM): inter-rater reliability of a new cutaneous assessment tool (CAT). Arthritis Rheum 38(Suppl):S168","journal-title":"Arthritis Rheum"},{"issue":"4","key":"813_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/rheumatology\/keg210","volume":"42","author":"LG Rider","year":"2003","unstructured":"Rider LG, Feldman BM, Perez MD et al (2003) Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. Rheumatology 42(4):591\u2013595","journal-title":"Rheumatology"},{"issue":"4","key":"813_CR29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1553-2712.2000.tb02249.x","volume":"7","author":"AJ Singer","year":"2000","unstructured":"Singer AJ, Thode HC, Hollander JE (2000) Research fundamentals: selection and development of clinical outcome measures. Acad Emerg Med 7(4):397","journal-title":"Acad Emerg Med"},{"issue":"6","key":"813_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/00002281-199911000-00006","volume":"11","author":"RD Sontheimer","year":"1999","unstructured":"Sontheimer RD (1999) Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 11(6):475\u2013482","journal-title":"Curr Opin Rheumatol"},{"key":"813_CR31","volume-title":"Cutaneous manifestations of rheumatic disease","author":"RD Sontheimer","year":"2003","unstructured":"Sontheimer RD et al (2003) Cutaneous manifestations of rheumatic disease. Lippincott Williams & Wilkins, Philadelphia"},{"key":"813_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/096120339700600204","volume":"6","author":"B Tebbe","year":"1997","unstructured":"Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6:96\u2013104","journal-title":"Lupus"},{"key":"813_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2133.1993.tb00150.x","volume":"128","author":"S Tiling-Grosse","year":"1993","unstructured":"Tiling-Grosse S, Rees J (1993) Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 128:69\u201374","journal-title":"Br J Dermatol"},{"issue":"6","key":"813_CR34","first-page":"783","volume":"11","author":"MB Urowitz","year":"1984","unstructured":"Urowitz MB, Gladmann DD, Tozman EC, Goldsmith CH (1984) The lupus activity criteria count (LACC). J Rheumatol 11(6):783\u2013787","journal-title":"J Rheumatol"},{"key":"813_CR35","first-page":"1088","volume":"125","author":"VP Werth","year":"2005","unstructured":"Werth VP, Fivenson D, Pandya A, Chen D, Rico J, Albrecht J, Jacobus D (2005) Multicenter randomized placebo-controlled clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance phase pemphigus vulgaris. JID 125:1088 (abstract)","journal-title":"JID"},{"key":"813_CR36","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/archderm.139.11.1490","volume":"139","author":"HC Williams","year":"2003","unstructured":"Williams HC (2003) Is a simple generic index of dermatologic disease severity an attainable goal? Arch Dermatol 139:1490","journal-title":"Arch Dermatol"},{"key":"813_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00403-006-0707-8","volume":"298","author":"U Mrowietz","year":"2006","unstructured":"Mrowietz U, Elder JT, Barker J (2006) The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res 298:309\u2013319","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"813_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","volume":"299","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, Mihai S, Zillikens D (2007) The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 299(1):1\u20138","journal-title":"Arch Dermatol Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0813-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-007-0813-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0813-2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-007-0813-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T19:17:18Z","timestamp":1630437438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-007-0813-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s00403-007-0813-2","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,6]]},"assertion":[{"value":"25 June 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}